Leben Care

Leben Care was a Singapore-based digital health and healthcare AI company focused on ophthalmology diagnostics, particularly automated retinal screening and image analysis. Its core product, Netra.AI, was positioned as a scalable, low-cost retinal risk profiling platform that used deep learning to analyze retinal images for preventable eye disease and blindness risk. The company operated as a health technology and diagnostics business rather than a therapeutic drug developer, so it did not have a traditional biopharma pipeline. Public startup and company-profile sources indicate the business was founded in 2016, raised angel funding from Inflection Point Ventures, and has since been listed as out of business or struck off. Overall, Leben Care appears to have been an ophthalmic AI diagnostics startup serving screening and care-delivery workflows rather than a pharma or biotech therapeutics company.